197 related articles for article (PubMed ID: 23059145)
21. Dose Timing of D-Cycloserine to Augment Exposure Therapy for Social Anxiety Disorder: A Randomized Clinical Trial.
Smits JAJ; Pollack MH; Rosenfield D; Otto MW; Dowd S; Carpenter J; Dutcher CD; Lewis EM; Witcraft SM; Papini S; Curtiss J; Andrews L; Kind S; Conroy K; Hofmann SG
JAMA Netw Open; 2020 Jun; 3(6):e206777. PubMed ID: 32496566
[TBL] [Abstract][Full Text] [Related]
22. D-cycloserine-augmented one-session treatment of specific phobias in children and adolescents.
Farrell LJ; Waters AM; Oar EL; Tiralongo E; Garbharran V; Alston-Knox C; McConnell H; Collings N; Zimmer-Gembeck M; Donovan CL; Testa C; Storch EA; Ollendick TH
Brain Behav; 2018 Jun; 8(6):e00984. PubMed ID: 30106248
[TBL] [Abstract][Full Text] [Related]
23. Augmentation of exposure therapy with post-session administration of D-cycloserine.
Tart CD; Handelsman PR; Deboer LB; Rosenfield D; Pollack MH; Hofmann SG; Powers MB; Otto MW; Smits JA
J Psychiatr Res; 2013 Feb; 47(2):168-74. PubMed ID: 23098672
[TBL] [Abstract][Full Text] [Related]
24. D-cycloserine augmented exposure therapy for obsessive-compulsive disorder.
Kushner MG; Kim SW; Donahue C; Thuras P; Adson D; Kotlyar M; McCabe J; Peterson J; Foa EB
Biol Psychiatry; 2007 Oct; 62(8):835-8. PubMed ID: 17588545
[TBL] [Abstract][Full Text] [Related]
25. Prescriptive variables for d-cycloserine augmentation of exposure therapy for posttraumatic stress disorder.
de Kleine RA; Hendriks GJ; Smits JA; Broekman TG; van Minnen A
J Psychiatr Res; 2014 Jan; 48(1):40-6. PubMed ID: 24183818
[TBL] [Abstract][Full Text] [Related]
26. Augmenting transcranial direct current stimulation with (D)-cycloserine for depression: a pilot study.
Chan HN; Alonzo A; Martin DM; Mitchell PB; Sachdev P; Loo CK
J ECT; 2013 Sep; 29(3):196-200. PubMed ID: 23792778
[TBL] [Abstract][Full Text] [Related]
27. Does yohimbine hydrochloride facilitate fear extinction in virtual reality treatment of fear of flying? A randomized placebo-controlled trial.
Meyerbroeker K; Powers MB; van Stegeren A; Emmelkamp PM
Psychother Psychosom; 2012; 81(1):29-37. PubMed ID: 22116378
[TBL] [Abstract][Full Text] [Related]
28. Glucocorticoids enhance in vivo exposure-based therapy of spider phobia.
Soravia LM; Heinrichs M; Winzeler L; Fisler M; Schmitt W; Horn H; Dierks T; Strik W; Hofmann SG; de Quervain DJ
Depress Anxiety; 2014 May; 31(5):429-35. PubMed ID: 24265104
[TBL] [Abstract][Full Text] [Related]
29. How specific is specific phobia? Different neural response patterns in two subtypes of specific phobia.
Lueken U; Kruschwitz JD; Muehlhan M; Siegert J; Hoyer J; Wittchen HU
Neuroimage; 2011 May; 56(1):363-72. PubMed ID: 21316468
[TBL] [Abstract][Full Text] [Related]
30. The predictive value of neural reward processing on exposure therapy outcome: Results from a randomized controlled trial.
Papalini S; Lange I; Bakker J; Michielse S; Marcelis M; Wichers M; Vervliet B; van Os J; Van Amelsvoort T; Goossens L; Schruers K
Prog Neuropsychopharmacol Biol Psychiatry; 2019 Jun; 92():339-346. PubMed ID: 30763673
[TBL] [Abstract][Full Text] [Related]
31. Impact of DCS-facilitated cue exposure therapy on brain activation to cocaine cues in cocaine dependence.
Prisciandaro JJ; Myrick H; Henderson S; McRae-Clark AL; Santa Ana EJ; Saladin ME; Brady KT
Drug Alcohol Depend; 2013 Sep; 132(1-2):195-201. PubMed ID: 23497788
[TBL] [Abstract][Full Text] [Related]
32. Dose timing of D-cycloserine to augment cognitive behavioral therapy for social anxiety: Study design and rationale.
Hofmann SG; Carpenter JK; Otto MW; Rosenfield D; Smits JA; Pollack MH
Contemp Clin Trials; 2015 Jul; 43():223-30. PubMed ID: 26111923
[TBL] [Abstract][Full Text] [Related]
33. Internet-based exposure treatment versus one-session exposure treatment of snake phobia: a randomized controlled trial.
Andersson G; Waara J; Jonsson U; Malmaeus F; Carlbring P; Ost LG
Cogn Behav Ther; 2013; 42(4):284-91. PubMed ID: 24245707
[TBL] [Abstract][Full Text] [Related]
34. Effects of D-cycloserine on extinction of mesolimbic cue reactivity in alcoholism: a randomized placebo-controlled trial.
Kiefer F; Kirsch M; Bach P; Hoffmann S; Reinhard I; Jorde A; von der Goltz C; Spanagel R; Mann K; Loeber S; Vollstädt-Klein S
Psychopharmacology (Berl); 2015 Jul; 232(13):2353-62. PubMed ID: 25697860
[TBL] [Abstract][Full Text] [Related]
35. Meta-analysis of functional brain imaging in specific phobia.
Ipser JC; Singh L; Stein DJ
Psychiatry Clin Neurosci; 2013 Jul; 67(5):311-22. PubMed ID: 23711114
[TBL] [Abstract][Full Text] [Related]
36. The functional neuroanatomy of blood-injection-injury phobia: a comparison with spider phobics and healthy controls.
Caseras X; Giampietro V; Lamas A; Brammer M; Vilarroya O; Carmona S; Rovira M; Torrubia R; Mataix-Cols D
Psychol Med; 2010 Jan; 40(1):125-34. PubMed ID: 19435544
[TBL] [Abstract][Full Text] [Related]
37. D-cycloserine as adjunct to brief computerised CBT for spider fear: Effects on fear, behaviour, and cognitive biases.
Kappelmann N; Suesse M; Steudte-Schmiedgen S; Kaldewaij R; Browning M; Michael T; Rinck M; Reinecke A
J Behav Ther Exp Psychiatry; 2020 Sep; 68():101546. PubMed ID: 31951819
[TBL] [Abstract][Full Text] [Related]
38. Extinction learning as a moderator of d-cycloserine efficacy for enhancing exposure therapy in posttraumatic stress disorder.
de Kleine RA; Smits JA; Hendriks GJ; Becker ES; van Minnen A
J Anxiety Disord; 2015 Aug; 34():63-7. PubMed ID: 26121495
[TBL] [Abstract][Full Text] [Related]
39. Amygdala hyperfunction in phobic fear normalizes after exposure.
Goossens L; Sunaert S; Peeters R; Griez EJ; Schruers KR
Biol Psychiatry; 2007 Nov; 62(10):1119-25. PubMed ID: 17706612
[TBL] [Abstract][Full Text] [Related]
40. Facilitation of fear extinction by D-cycloserine: theoretical and clinical implications.
Richardson R; Ledgerwood L; Cranney J
Learn Mem; 2004; 11(5):510-6. PubMed ID: 15466301
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
